You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 27, 2024

Carnegie Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for CARNEGIE, and what generic and branded alternatives to CARNEGIE drugs are available?

CARNEGIE has ten approved drugs.

Summary for Carnegie

US Patents:	0
Tradenames:	9
Ingredients:	9
NDAs:	10

Drugs and US Patents for Carnegie

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Carnegie	LETROZOLE	letrozole	TABLET;ORAL	091191-001	Jun 3, 2011	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Carnegie	OXCARBAZEPINE	oxcarbazepine	SUSPENSION;ORAL	218278-001	Mar 1, 2024	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Carnegie	AMINOCAPROIC ACID	aminocaproic acid	TABLET;ORAL	213928-001	Feb 12, 2021	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.